China's strategic push to boost innovation in the pharmaceutical sector is paying off big time! Global healthcare heavyweights are racing to expand their footprints in the country, thanks to policies that prioritize cutting-edge research and streamlined regulations. CGTN’s Zhu Zhu recently explored the buzzing Beijing Economic-Technological Development Area, where labs and factories hum with collaboration between international pharma leaders and local talent.
One exec at a top European drugmaker told reporters: 'China’s focus on developing new medicines and digital health tools makes it a goldmine for innovation.' The area has become a hotspot for R&D, with companies investing millions in AI-driven drug discovery and vaccine production facilities.
Analysts say this boom isn't just about profits—it’s creating jobs, accelerating tech transfers, and positioning China as a global healthcare partner. With over 15% growth in biotech exports last year alone, the momentum shows no signs of slowing.
Reference(s):
China's policies drive growth of global pharmaceutical giants
cgtn.com